{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:15:43Z","timestamp":1790810143402,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cancer Control Research Center, Cancer Control Foundation, Iran University of medical Sciences","award":["CCF-98035"],"award-info":[{"award-number":["CCF-98035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Triple-negative breast cancer (TNBC) does not respond to HER2-targeted and hormone-based medicines. Epidermal growth factor receptor 1 (EGFR1) is commonly overexpressed in up to 70% of TNBC cases, so targeting cancer cells via this receptor could emerge as a favored modality for TNBC therapy due to its target specificity. The development of mesoporous silica nanoparticles (MSNs) as carriers for siRNAs remains a rapidly growing area of research. For this purpose, a multi-functionalized KIT-6 containing the guanidinium ionic liquid (GuIL), PEI and PEGylated folic acid (FA-PEG) was designed. Accordingly, KIT-6 was fabricated and modified with FA-PEG and PEI polymers attached on the surface and the GuIL placed in the mesopores. Subsequent to confirming the structure of this multi-functionalized KIT-6- based nanocarrier using TEM, SEM, AFM, BET, BJH, DLS and Zeta Potential, it was investigated for uploading and transferring the anti-EGFR1 siRNAs to the MD-MBA-231 cell line. The rate of cellular uptake, cellular localization and endolysosomal escape was evaluated based on the fluorescent intensity of FAM-labelled siRNA using flowcytometry analysis and confocal laser scanning microscopy (CLSM). The 64% cellular uptake after 4\u00a0h incubation, clearly suggested the successful delivery of siRNA into the cells and, CLSM demonstrated that siRNA@[FA-PEGylated\/PEI@GuIL@KIT-6] may escape endosomal entrapment after 6\u00a0h incubation. Using qPCR, quantitative evaluation of EGFR1 gene expression, a knockdown of 82% was found, which resulted in a functional change in the expression of EGFR1 targets. Co-treatment of chemotherapy drug \u201ccarboplatin\u201d in combination with siRNA@[FA-PEGylated\/PEI@GuIL@KIT-6] exhibited a remarkable cytotoxic effect in comparison to carboplatin alone.<\/jats:p>","DOI":"10.1038\/s41598-022-21601-w","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T10:03:04Z","timestamp":1665741784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Overcoming the non-kinetic activity of EGFR1 using multi-functionalized mesoporous silica nanocarrier for in vitro delivery of siRNA"],"prefix":"10.1038","volume":"12","author":[{"given":"Javad","family":"Parnian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Ma\u2019mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Reza","family":"Bakhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Safavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"21601_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbacli.2015.03.003","volume":"3","author":"EA O\u2019Reilly","year":"2015","unstructured":"O\u2019Reilly, E. A. et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin. 3, 257\u2013275 (2015).","journal-title":"BBA Clin."},{"key":"21601_CR2","doi-asserted-by":"publisher","first-page":"vi19","DOI":"10.1093\/annonc\/mds190","volume":"23","author":"F Penault-Llorca","year":"2012","unstructured":"Penault-Llorca, F. & Viale, G. Pathological and molecular diagnosis of triple-negative breast cancer: A clinical perspective. Ann. Oncol. 23, vi19\u2013vi22 (2012).","journal-title":"Ann. Oncol."},{"key":"21601_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2008.04.008","volume":"13","author":"JA Engelman","year":"2008","unstructured":"Engelman, J. A. & Cantley, L. C. A sweet new role for EGFR in cancer. Cancer Cell 13, 375\u2013376 (2008).","journal-title":"Cancer Cell"},{"key":"21601_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccr.2008.03.015","volume":"13","author":"Z Weihua","year":"2008","unstructured":"Weihua, Z. et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 13, 385\u2013393 (2008).","journal-title":"Cancer Cell"},{"key":"21601_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40005-016-0296-2","volume":"47","author":"C Sarisozen","year":"2017","unstructured":"Sarisozen, C., Pan, J., Dutta, I. & Torchilin, V. P. Polymers in the co-delivery of siRNA and anticancer drugs to treat multidrug-resistant tumors. J. Pharm. Investig. 47, 37\u201349 (2017).","journal-title":"J. Pharm. Investig."},{"key":"21601_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3109\/1061186X.2011.622404","volume":"19","author":"O Taratula","year":"2011","unstructured":"Taratula, O., Garbuzenko, O. B., Chen, A. M. & Minko, T. Innovative strategy for treatment of lung cancer: Targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J. Drug Target. 19, 900\u2013914 (2011).","journal-title":"J. Drug Target."},{"key":"21601_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/nn800072t","volume":"2","author":"M Liong","year":"2008","unstructured":"Liong, M. et al. Multifunctional inorganic nanoparticles for imaging, targeting and drug delivery. ACS Nano 2, 889\u2013896 (2008).","journal-title":"ACS Nano"},{"key":"21601_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ajps.2018.01.006","volume":"13","author":"A Slita","year":"2018","unstructured":"Slita, A., Egorova, A., Casals, E., Kiselev, A. & Rosenholm, J. M. Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery. Asian J. Pharm. Sci. 13, 592\u2013599 (2018).","journal-title":"Asian J. Pharm. Sci."},{"key":"21601_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.addr.2008.03.012","volume":"60","author":"II Slowing","year":"2008","unstructured":"Slowing, I. I., Vivero-Escoto, J. L., Wu, C. W. & Lin, V. S. Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60, 1278\u20131288 (2008).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"21601_CR10","doi-asserted-by":"publisher","first-page":"109561","DOI":"10.1016\/j.biopha.2019.109561","volume":"125","author":"Y Song","year":"2020","unstructured":"Song, Y. et al. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC). Biomed. Pharmacother. 125, 109561 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"21601_CR11","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1002\/anie.200604488","volume":"46","author":"M Vallet-Reg\u00ed","year":"2007","unstructured":"Vallet-Reg\u00ed, M., Balas, F. & Arcos, D. Mesoporous materials for drug delivery. Angew. Chem.\u2014Int. Ed. 46, 7548\u20137558 (2007).","journal-title":"Angew. Chem.\u2014Int. Ed."},{"key":"21601_CR12","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2147\/IJN.S278724","volume":"16","author":"J Zhuang","year":"2021","unstructured":"Zhuang, J. et al. Tumour-targeted and redox-responsive mesoporous silica nanoparticles for controlled release of doxorubicin and an siRNA against metastatic breast cancer. Int. J. Nanomed. 16, 1961\u20131976 (2021).","journal-title":"Int. J. Nanomed."},{"key":"21601_CR13","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1039\/c0jm00645a","volume":"20","author":"SH Cheng","year":"2010","unstructured":"Cheng, S. H. et al. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics\u2014The trio of imaging, targeting and therapy. J. Mater. Chem. 20, 6149\u20136157 (2010).","journal-title":"J. Mater. Chem."},{"key":"21601_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00838-z","author":"PR Salekdeh","year":"2021","unstructured":"Salekdeh, P. R. et al. Bi-functionalized aminoguanidine-PEGylated periodic mesoporous organosilica nanoparticles: A promising nanocarrier for delivery of Cas9-sgRNA ribonucleoproteine. J. Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-021-00838-z (2021).","journal-title":"J. Nanobiotechnol."},{"key":"21601_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0142-9612(03)00566-0","volume":"25","author":"JF Chen","year":"2004","unstructured":"Chen, J. F., Ding, H. M., Wang, J. X. & Shao, L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25, 723\u2013727 (2004).","journal-title":"Biomaterials"},{"key":"21601_CR16","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1021\/ja028650l","volume":"125","author":"CY Lai","year":"2003","unstructured":"Lai, C. Y. et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451\u20134459 (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"21601_CR17","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jinorgbio.2007.12.028","volume":"102","author":"AJ Di Pasqua","year":"2008","unstructured":"Di Pasqua, A. J. et al. Cytotoxicity of mesoporous silica nanomaterials. J. Inorg. Biochem. 102, 1416\u20131423 (2008).","journal-title":"J. Inorg. Biochem."},{"key":"21601_CR18","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/smll.201000538","volume":"6","author":"J Lu","year":"2010","unstructured":"Lu, J., Liong, M., Li, Z., Zink, J. I. & Tamanoi, F. Biocompatibility, biodistribution and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6, 1794\u20131805 (2010).","journal-title":"Small"},{"key":"21601_CR19","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1039\/c0nr00156b","volume":"2","author":"JM Rosenholm","year":"2010","unstructured":"Rosenholm, J. M., Sahlgren, C. & Lind\u00e9n, M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles\u2014Opportunities & challenges. Nanoscale 2, 1870\u20131883 (2010).","journal-title":"Nanoscale"},{"key":"21601_CR20","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/smll.201200028","volume":"8","author":"HK Na","year":"2012","unstructured":"Na, H. K. et al. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores. Small 8, 1752\u20131761 (2012).","journal-title":"Small"},{"key":"21601_CR21","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.1016\/j.biomaterials.2011.08.068","volume":"32","author":"X Li","year":"2011","unstructured":"Li, X., Xie, Q. R., Zhang, J., Xia, W. & Gu, H. The packaging of siRNA within the mesoporous structure of silica nanoparticles. Biomaterials 32, 9546\u20139556 (2011).","journal-title":"Biomaterials"},{"key":"21601_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-00085-0","volume":"11","author":"R Heidari","year":"2021","unstructured":"Heidari, R., Khosravian, P., Mirzaei, S. A. & Elahian, F. siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells. Sci. Rep. 11, 1\u201314 (2021).","journal-title":"Sci. Rep."},{"key":"21601_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0167-4838(87)90192-0","volume":"916","author":"W Liu","year":"1987","unstructured":"Liu, W. & Tsou, C. L. Activity change during unfolding of bovine pancreatic ribonuclease A in guanidine. Biochim. Biophys. Acta (BBA)\/Protein Struct. Mol. 916, 455\u2013464 (1987).","journal-title":"Biochim. Biophys. Acta (BBA)\/Protein Struct. Mol."},{"key":"21601_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/bj3050379","volume":"305","author":"HJ Yang","year":"1995","unstructured":"Yang, H. J. & Tsou, C. L. Inactivation during denaturation of ribonuclease A by guanidinium chloride is accompanied by unfolding at the active site. Biochem. J. 305, 379 (1995).","journal-title":"Biochem. J."},{"key":"21601_CR25","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1080\/10837450.2020.1803909","volume":"25","author":"P Peyvand","year":"2020","unstructured":"Peyvand, P. et al. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: Response surface strategy to investigate and optimize loading and release process for Lapatinib delivery. Pharm. Dev. Technol. 25, 1150\u20131161 (2020).","journal-title":"Pharm. Dev. Technol."},{"key":"21601_CR26","doi-asserted-by":"publisher","first-page":"12682","DOI":"10.1021\/acssuschemeng.9b02585","volume":"7","author":"JA Kist","year":"2019","unstructured":"Kist, J. A., Henzl, M. T., Ba\u00f1uelos, J. L. & Baker, G. A. Calorimetric evaluation of the operational thermal stability of ribonuclease A in hydrated deep eutectic solvents. ACS Sustain. Chem. Eng. 7, 12682\u201312687 (2019).","journal-title":"ACS Sustain. Chem. Eng."},{"key":"21601_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/nar\/gkaa1280","volume":"49","author":"KS Egorova","year":"2021","unstructured":"Egorova, K. S., Posvyatenko, A. V., Larin, S. S. & Ananikov, V. P. Ionic liquids: Prospects for nucleic acid handling and delivery. Nucleic Acids Res. 49, 1201\u20131234 (2021).","journal-title":"Nucleic Acids Res."},{"key":"21601_CR28","first-page":"1","volume-title":"Advances in Genome Biology","author":"RR Sinden","year":"1998","unstructured":"Sinden, R. R., Pearson, C. E., Potaman, V. N. & Ussery, D. W. Advances in Genome Biology 1\u2013141 (Elsevier, 1998)."},{"key":"21601_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijbiomac.2005.11.008","volume":"37","author":"DV Svintradze","year":"2005","unstructured":"Svintradze, D. V. & Mrevlishvili, G. M. Fiber molecular model of atelocollagen-small interfering RNA (siRNA) complex. Int. J. Biol. Macromol. 37, 283\u2013286 (2005).","journal-title":"Int. J. Biol. Macromol."},{"key":"21601_CR30","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1021\/la9041919","volume":"26","author":"M Arsianti","year":"2010","unstructured":"Arsianti, M., Lim, M., Marquis, C. P. & Amal, R. Assembly of polyethylenimine-based magnetic iron oxide vectors: Insights into gene delivery. Langmuir 26, 7314\u20137326 (2010).","journal-title":"Langmuir"},{"key":"21601_CR31","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1016\/j.biomaterials.2010.01.123","volume":"31","author":"R Namgung","year":"2010","unstructured":"Namgung, R. et al. Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells. Biomaterials 31, 4204\u20134213 (2010).","journal-title":"Biomaterials"},{"key":"21601_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijpharm.2011.07.017","volume":"419","author":"Y Ma","year":"2011","unstructured":"Ma, Y., Zhang, Z., Wang, X., Xia, W. & Gu, H. Insights into the mechanism of magnetofection using MNPs-PEI\/pDNA\/free PEI magnetofectins. Int. J. Pharm. 419, 247\u2013254 (2011).","journal-title":"Int. J. Pharm."},{"key":"21601_CR33","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.2147\/IJN.S181440","volume":"13","author":"WJ Cheng","year":"2018","unstructured":"Cheng, W. J., Chen, L. C., Ho, H. O., Lin, H. L. & Sheu, M. T. Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR\/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy. Int. J. Nanomed. 13, 7079\u20137094 (2018).","journal-title":"Int. J. Nanomed."},{"key":"21601_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10904-009-9276-6","volume":"19","author":"S Ahmad","year":"2009","unstructured":"Ahmad, S., Riaz, U., Kaushik, A. & Alam, J. Soft template synthesis of super paramagnetic Fe3O4 nanoparticles a novel technique. J. Inorg. Organomet. Polym. Mater. 19, 355\u2013360 (2009).","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"21601_CR35","first-page":"16002","volume":"113","author":"X Sun","year":"2009","unstructured":"Sun, X. et al. Size-controlled synthesis of magnetite (Fe3O4) nanoparticles coated with glucose and gluconic acid from a single Fe(III) precursor by a sucrose bifunctional hydrothermal method. ACS Publ. 113, 16002\u201316008 (2009).","journal-title":"ACS Publ."},{"key":"21601_CR36","doi-asserted-by":"publisher","first-page":"13258","DOI":"10.1021\/la902089c","volume":"25","author":"EB Cho","year":"2009","unstructured":"Cho, E. B., Kim, D. & Jaroniec, M. Bifunctional periodic mesoporous organosilicas with thiophene and isocyanurate bridging groups. Langmuir 25, 13258\u201313263 (2009).","journal-title":"Langmuir"},{"key":"21601_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12033-012-9528-5","volume":"53","author":"W Denning","year":"2013","unstructured":"Denning, W. et al. Optimization of the transductional efficiency of lentiviral vectors: Effect of sera and polycations. Mol. Biotechnol. 53, 308\u2013314 (2013).","journal-title":"Mol. Biotechnol."},{"key":"21601_CR38","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s11051-013-1676-4","volume":"15","author":"HI Hussain","year":"2013","unstructured":"Hussain, H. I., Yi, Z., Rookes, J. E., Kong, L. X. & Cahill, D. M. Mesoporous silica nanoparticles as a biomolecule delivery vehicle in plants. J. Nanopart. Res. 15, 1676 (2013).","journal-title":"J. Nanopart. Res."},{"key":"21601_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","volume":"15","author":"S Hossen","year":"2019","unstructured":"Hossen, S. et al. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. J. Adv. Res. 15, 1\u201318 (2019).","journal-title":"J. Adv. Res."},{"key":"21601_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.drudis.2017.10.022","volume":"23","author":"N Poonia","year":"2018","unstructured":"Poonia, N., Lather, V. & Pandita, D. Mesoporous silica nanoparticles: A smart nanosystem for management of breast cancer. Drug Discov. Today 23, 315\u2013332 (2018).","journal-title":"Drug Discov. Today"},{"key":"21601_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2004.03.008","volume":"58","author":"M Bivas-Benita","year":"2004","unstructured":"Bivas-Benita, M., Romeijn, S., Junginger, H. E. & Borchard, G. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur. J. Pharm. Biopharm. 58, 1\u20136 (2004).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"21601_CR42","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","volume":"92","author":"O Boussif","year":"1995","unstructured":"Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92, 7297\u20137301 (1995).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21601_CR43","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/sj.gt.3300976","volume":"6","author":"WT Godbey","year":"1999","unstructured":"Godbey, W. T., Wu, K. K., Hirasaki, G. J. & Mikos, A. G. Improved packing of poly (ethylenimine)\/DNA complexes increases transfection efficiency. Gene Ther. 6, 1380\u20131388 (1999).","journal-title":"Gene Ther."},{"key":"21601_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0169-409X(01)00202-2","volume":"53","author":"R Kircheis","year":"2001","unstructured":"Kircheis, R., Wightman, L. & Wagner, E. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev. 53, 341\u2013358 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"21601_CR45","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/sj.gt.3301217","volume":"7","author":"Y Yamazaki","year":"2000","unstructured":"Yamazaki, Y. et al. Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine. Gene Ther. 7, 1148\u20131155 (2000).","journal-title":"Gene Ther."},{"key":"21601_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/nano7070189","volume":"7","author":"A Watermann","year":"2017","unstructured":"Watermann, A. & Brieger, J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials 7, 189 (2017).","journal-title":"Nanomaterials"},{"key":"21601_CR47","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/smll.200700005","volume":"3","author":"J Lu","year":"2007","unstructured":"Lu, J., Liong, M., Zink, J. I. & Tamanoi, F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3, 1341\u20131346 (2007).","journal-title":"Small"},{"key":"21601_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jconrel.2010.03.024","volume":"146","author":"G Acharya","year":"2010","unstructured":"Acharya, G. et al. A study of drug release from homogeneous PLGA microstructures. J. Control. Release 146, 201\u2013206 (2010).","journal-title":"J. Control. Release"},{"key":"21601_CR49","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.biomaterials.2008.09.035","volume":"30","author":"F Quaglia","year":"2009","unstructured":"Quaglia, F. et al. The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. Biomaterials 30, 374\u2013382 (2009).","journal-title":"Biomaterials"},{"key":"21601_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nnano.2007.108","volume":"2","author":"F Torney","year":"2007","unstructured":"Torney, F., Trewyn, B. G., Lin, V. S. Y. & Wang, K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2, 295\u2013300 (2007).","journal-title":"Nat. Nanotechnol."},{"key":"21601_CR51","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1021\/nn900918w","volume":"3","author":"T Xia","year":"2009","unstructured":"Xia, T. et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3, 3273\u20133286 (2009).","journal-title":"ACS Nano"},{"key":"21601_CR52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1590\/S1984-82502014000400004","volume":"50","author":"GF de Sousa","year":"2014","unstructured":"de Sousa, G. F., Wlodarczyk, S. R. & Monteiro, G. Carboplatin: Molecular mechanisms of action associated with chemoresistance. Brazilian J. Pharm. Sci. 50, 693\u2013701 (2014).","journal-title":"Brazilian J. Pharm. Sci."},{"key":"21601_CR53","doi-asserted-by":"publisher","first-page":"e07273","DOI":"10.1016\/j.heliyon.2021.e07273","volume":"7","author":"J Enciso-Benavides","year":"2021","unstructured":"Enciso-Benavides, J. et al. Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines. Heliyon 7, e07273 (2021).","journal-title":"Heliyon"},{"key":"21601_CR54","doi-asserted-by":"publisher","first-page":"18102","DOI":"10.1039\/C5RA25333K","volume":"6","author":"B Neuhaus","year":"2016","unstructured":"Neuhaus, B. et al. Nanoparticles as transfection agents: A comprehensive study with ten different cell lines. RSC Adv. 6, 18102\u201318112 (2016).","journal-title":"RSC Adv."},{"key":"21601_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/bio.2508","volume":"29","author":"T Horibe","year":"2014","unstructured":"Horibe, T. et al. Transfection efficiency of normal and cancer cell lines and monitoring of promoter activity by single-cell bioluminescence imaging. Luminescence 29, 96\u2013100 (2014).","journal-title":"Luminescence"},{"key":"21601_CR56","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1021\/acs.molpharmaceut.6b00102","volume":"13","author":"K M\u00fcller","year":"2016","unstructured":"M\u00fcller, K., Kessel, E., Klein, P. M., H\u00f6hn, M. & Wagner, E. Post-PEGylation of siRNA lipo-oligoamino amide polyplexes using tetra-glutamylated folic acid as ligand for receptor-targeted delivery. Mol. Pharm. 13, 2332\u20132345 (2016).","journal-title":"Mol. Pharm."},{"key":"21601_CR57","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.addr.2004.01.011","volume":"56","author":"A Gabizon","year":"2004","unstructured":"Gabizon, A., Shmeeda, H., Horowitz, A. T. & Zalipsky, S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv. Drug Deliv. Rev. 56, 1177\u20131192 (2004).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"21601_CR58","first-page":"1","volume":"1","author":"GL Zwicke","year":"2012","unstructured":"Zwicke, G. L., Mansoori, G. A. & Jeffery, C. J. Targeting of cancer nanotherapeutics. Nano Rev. 1, 1\u201311 (2012).","journal-title":"Nano Rev."},{"key":"21601_CR59","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1021\/mp800176t","volume":"6","author":"G Jiang","year":"2009","unstructured":"Jiang, G., Park, K., Kim, J., Ki, S. K. & Sei, K. H. Target specific intracellular delivery of siRNA\/PEI-HA complex by receptor mediated endocytosis. Mol. Pharm. 6, 727\u2013737 (2009).","journal-title":"Mol. Pharm."},{"key":"21601_CR60","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.bbapap.2011.04.005","volume":"1814","author":"M Falahati","year":"2011","unstructured":"Falahati, M. et al. Aminopropyl-functionalized cubic Ia3d mesoporous silica nanoparticle as an efficient support for immobilization of superoxide dismutase. Biochim. Biophys. Acta\u2014Proteins Proteom. 1814, 1195\u20131202 (2011).","journal-title":"Biochim. Biophys. Acta\u2014Proteins Proteom."},{"key":"21601_CR61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejpb.2010.11.008","volume":"77","author":"D Cun","year":"2011","unstructured":"Cun, D. et al. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization. Eur. J. Pharm. Biopharm. 77, 26\u201335 (2011).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"21601_CR62","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.1038\/s41598-018-34055-w","volume":"8","author":"T Jamali","year":"2018","unstructured":"Jamali, T. et al. In-vitro evaluation of apoptotic effect of OEO and thymol in 2D and 3D cell cultures and the study of their interaction mode with DNA. Sci. Rep. 8, 15787 (2018).","journal-title":"Sci. Rep."},{"key":"21601_CR63","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212\u00a0Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21601-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21601-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21601-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T22:13:34Z","timestamp":1701209614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21601-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21601"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21601-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17208"}}